3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Other solid neoplasm
2
Gynecologic
2
Gastrointestinal
2
Conditions
Ovarian Neoplasms
31
Peritoneal Neoplasms
28
Fallopian Tube Neoplasms
14
Stomach Neoplasms
13
Carcinoma, Ovarian Epithelial
13
Colorectal Neoplasms
11
Appendiceal Neoplasms
5
Neoplasm Metastasis
4
Uterine Neoplasms
3
Recurrence
3
Neoplasms
3
Uterine Cervical Neoplasms
2
Pseudomyxoma Peritonei
2
Pancreatic Neoplasms
2
Mesothelioma, Malignant
2
Mesothelioma
2
Colonic Neoplasms
2
Carcinoma
2
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pleural Effusion
1
Peritoneal Diseases
1
Pelvic Neoplasms
1
Ovarian Epithelial Cancer Recurrent
1
Ovarian Cancer Recurrent
1
Liposarcoma
1
Krukenberg Tumor
1
Hyperthermia
1
Gastrointestinal Neoplasms
1
Interventions
pembrolizumab
9
Nivolumab
5
fludarabine
4
Cyclophosphamide
4
amatuximab
3
Ipilimumab
3
Fluorouracil
3
Cisplatin
3
tislelizumab
2
spartalizumab
2
budigalimab
2
belinostat
2
Hyperthermic Intraperitoneal Chemotherapy
2
Cytoreduction Surgical Procedures
2
Carboplatin
2
venetoclax
1
talazoparib
1
rovalpituzumab tesirine
1
ribociclib
1
rebastinib
1
obinutuzumab
1
naptumomab estafenatox
1
fludarabine phosphate
1
epacadostat
1
durvalumab
1
bosutinib
1
atezolizumab
1
aldesleukin
1
Valacyclovir
1
Surgical Procedures, Operative
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Mesothelioma
×
Hyperthermic Intraperitoneal Chemotherapy
×
Gynecologic
×
Clear all
NCT02349958
2019-04-16
HIPEC/IPHC
Bay Area Gynecology Oncology
Phase 2
Unknown
200 enrolled
NCT00454519
2009-02-13
IPHC
Wuhan University
Phase 2
Unknown
60 enrolled